PreveCeutical Medical (TSE:PREV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PreveCeutical Medical’s subsidiary, BioGene Therapeutics, has appointed Professor Mirela Delibegovic to its Scientific Advisory Board, enhancing their expertise in metabolic health research. Her extensive background in diabetes and obesity research is expected to significantly contribute to BioGene’s innovative therapeutic programs.
For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.